Category Archives: Regulations

Clinical trials firm nutraceuticals position

As you know, the emergence of our increasingly health conscious public is driving the growth of the nutraceutical industry. It is one of the fastest-growing industries worldwide (Forbes, 2013) and is already highly profitable. In 2012, Forbes reported that nutrient supplements … Continue reading

Posted in Nutraceuticals, Regulations | Leave a comment

Clinical trials with negative results – to publish or not to publish?

A “finding” – what does it mean? In a clinical trial language a finding is usually referred to a numerical result of an analysis for a specific outcome, for example a relative risk (1). In proper understanding of research it … Continue reading

Posted in Regulations | Leave a comment

New EU Trial Regulations – Time Will Tell……

All those engaged in trials within Europe should be familiar – at least to some degree if not intimately – with the ‘Clinical Trials Directive’ (or to give it its full, and understandably seldom used, full document title: ‘Directive 2001/20/EC … Continue reading

Posted in EMA, European Union, Regulations | Leave a comment

New EMA policy on access to clinical trial data – still a hot topic

Transparency of data is paramount to scientific communities worldwide and a sine qua non for the unbiased technological advancement. This, naturally, also refers to scientific research in medicine. As we read on through the European Medicines Agency’s (EMA) mission and responsibilities, … Continue reading

Posted in EMA, European Union, Regulations | Leave a comment